Keiji Tsuji Selected Research

Keiji Tsuji Research Topics

Disease

24	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 03/2014
16	Infections 11/2022 - 12/2007
15	Chronic Hepatitis C 04/2024 - 01/2007
10	Fibrosis (Cirrhosis) 04/2024 - 03/2017
9	Neoplasms (Cancer) 01/2024 - 11/2006
7	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 07/2006
4	Hepatitis C 01/2022 - 06/2009
4	Liver Diseases (Liver Disease) 03/2021 - 12/2007
4	Neoplasm Metastasis (Metastasis) 10/2018 - 03/2014
3	Chronic Hepatitis (Chronic Active Hepatitis) 04/2024 - 03/2017
3	Disease Progression 05/2022 - 08/2018
2	Fatigue 11/2023 - 11/2022
2	Proteinuria 11/2023 - 01/2023
2	Chemical and Drug Induced Liver Injury 05/2023 - 08/2020
2	Fever (Fevers) 11/2022 - 01/2021
2	Thrombosis (Thrombus) 02/2018 - 01/2018
2	Anemia 06/2017 - 05/2005
1	Anorexia 11/2023
1	Hypertension (High Blood Pressure) 11/2023
1	Chronic Hepatitis B 01/2023
1	Injection Site Reaction 11/2022
1	Ascites 06/2022
1	Thrombocytopenia (Thrombopenia) 03/2021
1	Diabetes Mellitus 03/2021
1	Esophagitis 01/2021
1	Hepatic Encephalopathy 11/2020
1	Coinfection 01/2020
1	Hepatitis 01/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Exanthema (Rash) 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Carcinoma (Carcinomatosis) 03/2014
1	Gastrointestinal Hemorrhage (Hematochezia) 03/2014
1	Abdominal Pain (Pain, Abdominal) 02/2009

Drug/Important Bio-Agent (IBA)

10	Antiviral Agents (Antivirals)IBA 07/2022 - 01/2018
10	Ribavirin (Virazole)FDA LinkGeneric 12/2020 - 01/2007
9	SofosbuvirIBA 11/2021 - 06/2017
8	daclatasvirIBA 05/2022 - 01/2016
8	asunaprevirIBA 05/2022 - 01/2016
7	lenvatinibIBA 11/2023 - 01/2020
7	InterferonsIBA 11/2021 - 12/2007
6	Sorafenib (BAY 43-9006)FDA Link 09/2023 - 09/2015
5	atezolizumabIBA 11/2023 - 12/2022
5	Bevacizumab (Avastin)FDA Link 11/2023 - 12/2022
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 03/2019
4	BilirubinIBA 01/2023 - 07/2006
3	Alanine Transaminase (SGPT)IBA 11/2022 - 01/2018
3	AlbuminsIBA 10/2022 - 06/2022
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2006
3	velpatasvirIBA 11/2021 - 11/2020
3	ledipasvirIBA 12/2018 - 11/2017
2	glecaprevir and pibrentasvirIBA 04/2024 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2020
2	Fetal Proteins (Fetoprotein)IBA 07/2022 - 07/2016
2	LipidsIBA 08/2020 - 11/2017
2	RNA (Ribonucleic Acid)IBA 04/2018 - 06/2009
2	sofosbuvir drug combination ledipasvirIBA 04/2018 - 11/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2024
1	HLA-B Antigens (HLA-B)IBA 05/2023
1	nasIBA 01/2023
1	NucleotidesIBA 11/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2022
1	NucleosidesIBA 11/2022
1	Thrombopoietin ReceptorsIBA 03/2021
1	lusutrombopagIBA 03/2021
1	RamucirumabIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	regorafenibIBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Cholinesterases (Cholinesterase)IBA 01/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2019
1	elbasvirIBA 10/2019
1	pibrentasvirIBA 10/2019
1	grazoprevirIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	glecaprevirIBA 10/2019
1	Serum AlbuminIBA 03/2019
1	ombitasvirIBA 12/2018
1	paritaprevirIBA 12/2018
1	Ritonavir (Norvir)FDA Link 12/2018
1	Antithrombin IIIIBA 02/2018
1	Inosine TriphosphataseIBA 06/2017
1	Hemoglobins (Hemoglobin)IBA 06/2017
1	SimeprevirIBA 03/2017
1	Fluorouracil (Carac)FDA LinkGeneric 07/2016
1	Mesylates (Mesylate)IBA 02/2009
1	Eicosapentaenoic AcidIBA 01/2007

Therapy/Procedure

30	Therapeutics 04/2024 - 01/2007
4	Drug Therapy (Chemotherapy) 10/2018 - 09/2015
3	Retreatment 12/2020 - 04/2018
3	Radiotherapy 01/2018 - 11/2006
2	Aftercare (After-Treatment) 01/2022 - 01/2016
2	Renal Dialysis (Hemodialysis) 08/2018 - 01/2018
2	Hepatectomy 01/2018 - 03/2014
1	Kampo Medicine (Kampo) 05/2023
1	Nephrectomy 01/2019
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 03/2017